[Discover BAM15 peptide therapy] Tesamorelin Critical for Tier 3 patients as visceral fat is a primary driver of metabolic disease, systemic inflammation, fatigue, and brain fog
A novel therapeutic target for DM are incretin-based therapies, glucagon-like peptide-1 (GLP-1), and gastric-inhibitory-polypeptide (GIP) are released from the gastrointestinal tract (GIT) and act on the beta cell of pancreatic islets by increasing the secretion of insulin
These foods not only help in maintaining muscle mass but also aid in regulating appetite and glucose metabolism, indirectly supporting GLP-1 function
Furthermore, these substantial results are typically realized over a specific timeframeoften 68 weeksemphasizing that this is a long-term medical journey, and success requires patience, strict adherence, and the close supervision of a medical professional
Mortensen K, Christensen LL, Holst JJ, and Orskov C
For patients preparing for pregnancy, I often turn to alternatives such as myo-inositol, berberine, or metformin, along with nutrition and lifestyle interventions , which can support insulin sensitivity without the same safety concerns